Innovative clearance data model for demining operational data collection: Insights from field trials in Zimbabwe.

From September 2023 to March 2024 a field trial on a live manual demining site was conducted to test a new and innovative approach for the collection and analysis of operational data. The approach, titled the Clearance Data Model, involved the collection of sixty-six data attributes for each mine found. For the first time the mine itself would become the accountable unit of demining data, against which an expanded range of relevant attributes particular to that specific mine would be recorded.

Evaluation of the ASPYRE-Lung targeted variant panel: a rapid, low-input solution for non-small cell lung cancer biomarker testing and experience from three independent sites.

Background: Many patients with non-small cell lung cancer (NSCLC) lack access to highly effective approved targeted therapeutics due to multiple gaps in biomarker testing. Challenges in comprehensive molecular testing include complexities associated with the need to assess the presence of multiple variants, costs of running multiple sequential assays per sample, high assay quality control (QC) failure rates, clinical need for rapid turn-around time (TAT) to initiate therapy, and insufficient tissue samples. The ASPYRE-Lung NSCLC assay addresses gaps in multiplexed testing by simultaneously analyzing DNA and RNA, detecting 114 actionable genomic variants across 11 genes, consistent with current NSCLC treatment guidelines.